iShares MSCI Europe UCITS ETF EUR (Acc) (SWX: IMEA)
Switzerland
· Delayed Price · Currency is CHF | Assets | 7.75B |
| Expense Ratio | 0.12% |
| PE Ratio | 14.82 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +12.85% |
| Volume | 4,025 |
| Open | 74.13 |
| Previous Close | 75.23 |
| Day's Range | 74.13 - 74.46 |
| 52-Week Low | 66.00 |
| 52-Week High | 79.43 |
| Beta | 0.91 |
| Holdings | 456 |
| Inception Date | Sep 25, 2009 |
About IMEA
iShares MSCI Europe UCITS ETF EUR (Acc) is an exchange traded fund launched by BlackRock Asset Management Ireland Limited. The fund is managed by BlackRock Advisors (UK) Limited. It invests in the public equity markets of developed countries in Europe. The fund seeks to invest in the stocks of companies operating across diversified sectors. It invests in the stocks of mid-cap and large-cap companies. The fund seeks to replicate the performance of the MSCI Europe Index, by employing representative sampling methodology. It was formerly known as iShares III Public Limited Company - iShares MSCI Europe UCITS ETF (Acc). iShares MSCI Europe UCITS ETF EUR (Acc) was formed on September 25, 2009 and is domiciled in Ireland.
Performance
IMEA had a total return of 12.85% in the past year. Since the fund's inception, the average annual return has been 7.60%, including dividends.
Top 10 Holdings
23.09% of assets| Name | Symbol | Weight |
|---|---|---|
| Novo Nordisk A/S | NOVO.B | 3.87% |
| ASML Holding N.V. | ASML | 3.15% |
| Nestlé S.A. | NESN | 2.43% |
| AstraZeneca PLC | AZN | 2.36% |
| Novartis AG | NOVN | 2.07% |
| Roche Holding AG | ROG | 2.07% |
| SAP SE | SAP | 2.01% |
| Shell plc | SHEL | 1.94% |
| LVMH Moët Hennessy - Louis Vuitton, Société Européenne | MC | 1.79% |
| HSBC Holdings plc | HSBA | 1.41% |